Shares of healthcare facilities operator Select Medical (NYSE:SEM) are trending lower today after its third-quarter bottom line fell short of estimates.
Revenue inched up 2.6% year-over-year to $1.57 billion, sneaking past estimates by $10 million. EPS at $0.21 though, missed the cut by a margin of $0.24.
While revenue from the critical illness recovery hospital segment dropped ~1%, revenue from the rehabilitation hospital segment increased by 8% during this period.
The company has reiterated its 2022 guidance expecting revenue to land between $6.25 billion and $6.40 billion.
Further, it continues to expect compound annual growth between 4% and 6% for its top line for 2021 through 2023.
Read full Disclosure
